tiprankstipranks
Advertisement
Advertisement
Neurotech Investors Back Capital Raisings and Director Participation at General Meeting
PremiumCompany AnnouncementsNeurotech Investors Back Capital Raisings and Director Participation at General Meeting
1M ago
Neurotech Narrows Half-Year Loss as Revenue Doubles
Premium
Company Announcements
Neurotech Narrows Half-Year Loss as Revenue Doubles
1M ago
Neurotech’s NTI164 Shows Strong Long-Term Safety in Key Toxicology Study
Premium
Company Announcements
Neurotech’s NTI164 Shows Strong Long-Term Safety in Key Toxicology Study
2M ago
Neurotech Issues New Shares, Affirms Regulatory Compliance
PremiumCompany AnnouncementsNeurotech Issues New Shares, Affirms Regulatory Compliance
4M ago
Neurotech Seeks ASX Quotation for 246.7 Million New Shares
Premium
Company Announcements
Neurotech Seeks ASX Quotation for 246.7 Million New Shares
4M ago
Neurotech Director’s 5 Million Options Lapse, Reducing Potential Equity Exposure
Premium
Company Announcements
Neurotech Director’s 5 Million Options Lapse, Reducing Potential Equity Exposure
4M ago
Neurotech Secures $4.73 Million R&D Tax Incentive for Clinical Advancements
PremiumCompany AnnouncementsNeurotech Secures $4.73 Million R&D Tax Incentive for Clinical Advancements
5M ago
Neurotech Expands NTI164 Access and Gains FDA Designation
Premium
Company Announcements
Neurotech Expands NTI164 Access and Gains FDA Designation
6M ago
Neurotech International Announces 2025 Annual General Meeting
Premium
Company Announcements
Neurotech International Announces 2025 Annual General Meeting
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100